Endogenous hyperinsulinism secondary to insulinoma. A case report

Authors

  • Sandra Herranz-Antolín Servicio de Endocrinología y Nutrición, Hospital Universitario de Guadalajara, Guadalajara, Spain
  • Alberto Serrano-Martínez Servicio de Medicina Interna, Hospital Universitario de Guadalajara, Guadalajara, Spain
  • Visitación Álvarez-de Frutos Servicio de Endocrinología y Nutrición, Hospital Universitario de Guadalajara, Guadalajara, Spain
  • Antonio Candia-Fernández Servicio de Anatomía Patológica, Hospital Universitario de Guadalajara, Guadalajara, Spain

DOI:

https://doi.org/10.32818/reccmi.a2n2a4

Keywords:

insulinoma, endogenour hyperinsulinism, hypoglucemia

Abstract

A 61 year-old woman was referred to Endocrinology department for the study of dizziness episodes without the sensation of spinning objets, as well as nervousness, palpitations and tremors. All of which improved after intake of carbohydrates. After a clinical suspicion of hypoglycemia and the complementary tests were performed, the patient was diagnosed with endogenous hyperinsulinism. The possibility of factitious hypoglycemias was dismissed. An endoscopic ultrasonography was performed, through which a pancreatic insulinoma was diagnosed that was non-visible on computed tomography. Finally, an enucleation of the lesion was performed, after which the clinical symptomatology was resolved. The patient remains asymptomatic at the present time.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Cryer P, Axelrod L, Grossman A. Evaluation and management of adult hypoglycemic disorders: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009; 94: 709-28.

Palomares R, Zurera L, Gálvez MA, Tofe S, Canis M, Benito P. Utilidad de la arteriografía con inyección intraarterial selectiva de calcio en el diagnóstico del insulinoma. Med Clin (Barc). 2002; 119: 568-70.

Diéguez M, Riestra M, Menéndez E. Insulinoma: criterios diagnósticos y tratamiento. Av Diabetol. 2009; 25: 293-9.

Kimberly A, Placzkowsky K, Vella A. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009; 94: 1069-1073.

Dizon AM, Kowalyk S, Hoogwerf BJ. Neuroglycopenic and other symptoms in patients with insulinomas. Am J Med. 1999; 106: 307-10.

Guettier JM, Kam A, Chang R, Skarulis MC, Cochran C, Alexander HR. Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH Experience. J Clin Endocrinol Metab. 2009; 94: 1074-80.

Bassam A, Joe B. Occult sporadic insulinoma. Localization and surgical strategy. World J Gastroenterol. 2008; 14: 657-665.

Kauhanen S, Seppänen M, Minn H, Gullichsen R, Salonen A, Alanen K. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or ß-cell hyperplasia in adult patients. J Clin Endocrinol Metab. 2009; 92: 1237-44.

Published

2017-08-31

How to Cite

1.
Herranz-Antolín S, Serrano-Martínez A, Álvarez-de Frutos V, Candia-Fernández A. Endogenous hyperinsulinism secondary to insulinoma. A case report. Rev Esp Casos Clin Med Intern [Internet]. 2017 Aug. 31 [cited 2024 Nov. 22];2(2):71-3. Available from: https://www.reccmi.com/RECCMI/article/view/158

Most read articles by the same author(s)